Skip to content
Synaptiq.io logo — Transforming cancer treatment through AI-assisted radiothera...

Synaptiq.io

Transforming cancer treatment through AI-assisted radiotherapy

Founded 2020 Romania Romania 21 employees Grant Total: $1.34M AI, Health Care

General Information

Company Name Synaptiq.io
Founded Year 2020
Location Romania Romania
Employees 21
Industries AI, Health Care
Funding Stage Grant
Business Model B2B, SaaS
Revenue Model Subscription, Usage Based, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Synaptiq.io. To contact Synaptiq.io, visit synaptiq.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Synaptiq.io compare?

A PDF of Synaptiq.io and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Synaptiq.io soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Synaptiq.io

Synaptiq.io, founded in 2020 and headquartered in Romania, is pioneering advancements in the healthcare sector with its innovative approach to cancer treatment. The company's slogan, "Transforming cancer treatment through AI-assisted radiotherapy," encapsulates its mission of leveraging AI technology to improve patient outcomes.

Synaptiq.io's core solution addresses the labor-intensive process of contouring tumors and organs at risk during radiotherapy, traditionally a task requiring up to four hours. Through their sophisticated AI-driven software, this process is optimized and reduced to as little as five minutes, significantly improving efficiency and allowing medical professionals to dedicate more time to patient care.

Operating at the intersection of AI and Health Care, Synaptiq.io remains a compelling prospect for investors by showcasing the tangible impact of technology in medicine. Their most recent funding came in the form of a Grant investment on 06 June 2023, underscoring a growing recognition and support for their mission and innovative solutions.

Business keywords: AI-driven radiotherapy, cancer treatment, automated contouring, deep learning pipelines, telemedicine integration, medical software development, personalized analytics, medical imaging software, workflow automation, tumor contouring, AI in medicine, radiotherapy solutions, patient outcome improvement, MedTech solutions

Services & Products

AI-driven Contouring for Radiotherapy
Automated Treatment Planning
AI-based Diagnostic Assistance

Target Customers

Radiation Oncologists Radiotherapy Centers Cancer Patients

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed -
06 Jun 2023
Venture Round €440.00K 4
Gapminder Ventures, Fortech Investments +2
04 Apr 2023
Seed Round €650.00K 1
SeedBlink
02 Apr 2023
Grant Undisclosed 1
InnovX
15 Jun 2022
Pre Seed Round €250.00K -
01 Jan 2020

Synaptiq.io Alternatives & Competitors

View All Alternatives
Synaptiq.io vs
MVision AI
MVision AI Finland

MVision AI is a pioneering software service provider for precision radiotherapy treatment planning.

Seed
56 employees
AI, Biotechnology
Synaptiq.io vs
AMG Medtech
AMG Medtech United Kingdom

Streamlining cancer care through AI

2 employees
AI, Health Care
Synaptiq.io vs
Aevus Precision Rx
Aevus Precision Rx United States

Machine-Learning powered prescription guidance for Type 2 Diabetes

2-10 employees
AI, Biotechnology

FAQ About Synaptiq.io

Transforming cancer treatment through AI-assisted radiotherapy
Synaptiq.io was founded in 2020.
Synaptiq.io is headquartered in Romania.
Synaptiq.io operates in AI and Health Care. Its work centres on AI-driven radiotherapy, cancer treatment, automated contouring and deep learning pipelines. Its customers include Radiation Oncologists, Radiotherapy Centers and Cancer Patients.
Synaptiq.io has a B2B and SaaS business model. Its revenue comes from Subscription, Usage Based and Licensing.
Synaptiq.io has approximately 21 employees.
Synaptiq.io has completed 5 funding rounds, raising a total of $1.34M. The latest funding stage is Grant.
Synaptiq.io offers: AI-driven Contouring for Radiotherapy, Automated Treatment Planning, AI-based Diagnostic Assistance.
Top alternatives and competitors to Synaptiq.io include MVision AI, AMG Medtech, Aevus Precision Rx, Clairity, Inc., Delphyr. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Synaptiq.io and MVision AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Synaptiq.io, https://bouncewatch.com/company/synaptiqio, updated 3 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout